Figure 2.
The prognostic significance of PRSS23 overexpression was analyzed in the GC cohort from GSE62254. (A) Differences in PRSS23 expression between intestinal and diffuse tissues of GC. (B) PRSS23 was highly expressed in GC patients with positive MLH1 expression. (C–F) PRSS23 expression level in different TNM-stages and Pathologic stages of GC tissues. (G, H) PRSS23 overexpression predicted shorter overall survival time and disease-free survival time in GC. **, P < 0.01.